Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
04/2002
04/25/2002US20020049195 Urea compounds that are muscarinic receptor antagonists and agonists, administering to the mammal the urea compound to treat urinary incontinence, chronic pulmonary obstructive disease, asthma, hyper salivation, blurred vision etc.
04/25/2002US20020049190 Useful in binding nitric oxide; inhibiting tumor growth
04/25/2002CA2426103A1 New cephalotaxanes, their method of preparation and their use in treatment of cancers, leukemias, parasites including thus resistant to usual chemotherapeutic agents and as reversal agents
04/25/2002CA2423789A1 Bridged piperazine derivatives
04/25/2002CA2422717A1 2-, 3-, 4-, or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy
04/24/2002EP1199308A2 Process for the preparation of imidazodiazepine intermediates
04/24/2002EP1199306A1 Biarylurea derivatives
04/24/2002EP1199070A2 Use of PDE V inhibitors for improved fecundity in mammals
04/24/2002EP1198464A1 8-PHENYL-6,9-DIHYDRO- 1,2,4]TRIAZOLO 3,4- i i /i ]PURIN-5-ONE DERIVATIVES
04/24/2002EP0963425B1 Fluorescent compositions and their use
04/24/2002EP0714298B1 Photosensitiser containing phthalocyanine derivative for photodynamic therapy of tumours
04/24/2002CN1346357A Process for production of optically active pyrrolazepine derivatives
04/24/2002CN1346354A Substituted benzoylpyrazoles as herbicides
04/24/2002CN1346351A 1,2-benzothiazepines for the treatment of hyperlipidemic diseases
04/24/2002CN1345725A Diaze tropihidine indole for treating chronic obstructive disease of lung
04/24/2002CN1083453C Fused imidazole derivatives as emultidrug resistance modulators
04/24/2002CN1083442C Process for prepn of tetraazaacrocycles
04/24/2002CN1083244C Zilpaterol hydrochloride in specific crystallized formits prepn. process and intermediate products used
04/23/2002US6376681 Synthesis of compounds useful in the manufacture of ketorolac
04/23/2002US6376667 Cyclization in presenc eof base
04/23/2002US6376664 Detectors, catalyst
04/23/2002US6376487 Oxadiazine derivatives
04/23/2002US6376483 Bacteriochlorins and bacteriopurpurins useful as photoselective compounds for photodynamic therapy and a process for their production
04/23/2002US6375962 React with alkylating agents such as mustard gas; may contain perfluoropolymers which are effective barrier compounds for pesticides, industrial solvents and chemical warfare agents
04/23/2002CA2093361C Porphyrin derivative
04/23/2002CA2032261C Antiviral polyheterocyclic dimers
04/20/2002CA2359383A1 Use of pdev inhibitors for improved fecundity in mammals
04/18/2002WO2002030933A1 Substituted 3.4-dihydro-pyrido[1,2-a]pyrimidines
04/18/2002WO2002030931A2 Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
04/18/2002WO2002030930A2 Aza- and polyaza-naphthalenyl carboxamides useful as hiv integrase inhibitors
04/18/2002WO2002030911A1 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
04/18/2002WO2002030886A2 Heterocyclic angiogenesis inhibitors
04/18/2002WO2002030428A1 Use of substituted imidazo[1,2-a]pyridine-, imidazo[1,2-a]pyrimidine and imidazo[1,2-a]pyrazine-3-yl-amine derivatives for producing nos-inhibiting medicaments
04/18/2002WO2002030405A2 Treatment of affective disorders by the combined action of a nicotinic receptor agonist and a monoaminergic substance
04/18/2002WO2002030190A1 Method of inactivating viral particles in a blood product
04/18/2002WO2002017914A3 Fused pyrrolocarbazoles against inflammation
04/18/2002WO2001079207A3 A process for the preparation of decahydro-2a,4a,6a,8a-tetraazacyclopent[fg]acenaphthylene and functionalized derivatives
04/18/2002US20020045759 E.g., N-(2-Phenylsulfonyl-1-ethyl)-3-(4-Cyanophenyl)-2,3-dihydro-imidazo(2,1 -b)thiazole-5-carboxamide hydrochloride; treating cancer, neurofibromin benign proliferative disorder, retinal vascularization, and hepatitis delta
04/18/2002US20020045635 Novel mGluR antagonists and a method for their synthesis
04/18/2002US20020045631 Enhancement of the efficacy of triazolopyrimidines
04/18/2002US20020045630 Antiproliferative, -carcinogenic, -tumor and -diabetic agents; binding to or modulating the human kinase insert-domain-containing receptor (KDR) or the murine fetal liver kinase 1 (FLK-1) receptor; vasculogenesis; angiogenesis
04/18/2002US20020045624 Treatment of central nervous system (CNS) dysfunctions, neurodegenerative diseases and neurotoxic injury following hypoxia, anoxia or ischemia of stroke, cardiac arrest or perinatal asphyxia; antipsychotic and -convulsant agents
04/18/2002US20020045623 Stable; potent; penetrates cell membranes; effectively hinders cellular apoptosis; Antiinflammatory agents, Ischemic agents, cancer, autoimmune diseases and nervous system disorders.
04/18/2002US20020045622 Growth hormone secretagogues
04/18/2002US20020045617 Act preferentially on M4 receptors; side effect reduction; used to treat nervous system disorders, psychological disorders and as an analgesic; Alzheimer's disease; Cognition activators.
04/18/2002DE10050663A1 Use of amino-substituted imidazo(1,2-a)pyridine, imidazo(1,2-a)pyrimidine and imidazo(1,2-a)pyrazine derivatives as NO synthase inhibitors, e.g. in treatment of migraine and neurodegenerative diseases
04/18/2002DE10050662A1 New substituted dihydropyrido-pyrimidine derivatives, useful for treating e.g. pain, urinary incontinence and tinnitus
04/18/2002DE10050661A1 New substituted 3,4-dihydro-pyrimido(1,2-a)pyrimidine and 3,4-dihydro-pyrazino(1,2-a)pyrimidine derivatives useful for the treatment of pain, urinary incontinence, pruritis, tinnitus and diarrhea
04/18/2002CA2459746A1 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
04/18/2002CA2425672A1 Use of substituted imidazo[1,2-a]-pyridin-,pyrimidin-and -pyrazin-3-yl-amine derivatives in the preparation of medicaments for inhibiting nos
04/18/2002CA2425666A1 Substituted 3.4-dihydro-pyrido[1,2-a]pyrimidines
04/17/2002EP1197147A1 Method of inactivating viral particles in a blood product
04/17/2002EP1196626A2 Methods for identifying inhibitors of signaling molecules
04/17/2002EP1196419A1 Potassium channel blocking agents
04/17/2002EP1196418A1 METHOD FOR PREPARING SUBSTITUTED 1,4]DIAZEPINO 6,7,1- i hi /i ]INDOL-4-ONES
04/17/2002EP1196417A1 1,2,3,4,5,6-HEXAHYDROAZEPINO 4,5-b]INDOLES CONTAINING ARYLSULFONES AT THE 9-POSITION
04/17/2002EP1196398A1 Bridged fluorescent dyes, their preparation and their use in assays
04/17/2002EP1015434B1 Novel pyrimidin-4-one and pyrimidin-4-thione as fungicide
04/17/2002EP0998475B1 Novel compounds
04/17/2002EP0996620B1 Novel compounds
04/17/2002EP0968212B1 Method of making (1s, 4r)-1-azabicyclo 2.2.1]heptan-3-one and (1r, 4s), 1-azabicyclo 2.2.1]heptan-3-one
04/17/2002EP0807632B1 Pyrroloazepine derivatives
04/17/2002CN1345320A Diazabicyclic derivatives as nicotinic acetylcholine receptor ligands
04/17/2002CN1345240A Improved cancer treatment with temozolomide
04/17/2002CN1344718A New phthalocyanine derivative and its application
04/17/2002CN1344717A Quaternary ammonium salt compound of piperazine with pain relieving effect
04/17/2002CN1082963C Isoxazolidine derivatives
04/17/2002CN1082953C Process to prepare oxazolidinones
04/16/2002US6372749 Pharmacological effects such as analgesic action, inhibitory effect on nitrogen monoxide synthetase and the like and are useful as analgesics.
04/16/2002US6372745 2,3,4,4A-tetrahydro-1H-pyrazino[1,2-A]quinoxalin-5(6H)one derivatives
04/16/2002US6372743 Certain alkylene diamine-substituted pyrazlo (1,5-a)-1,5-pyrimidines and pyrazolo (1,5-a) 1,3,5-triazines
04/16/2002US6372735 Antihistamines
04/16/2002US6372727 Metalloporphyrin treatment of neurologic disease
04/16/2002CA2169719C Pyrazolo[1,5-a]pyrimidine derivative
04/16/2002CA2103556C Bicyclopolyazamacrocyclophosphonic acids, their complexes and conjugates, for use as contrast agents, and processes for their preparation
04/16/2002CA2076948C Isatineoxime derivatives, their preparation and use
04/11/2002WO2002028874A2 Tumor proliferation inhibitors
04/11/2002WO2002028861A2 Methods and compounds for treating proliferative diseases
04/11/2002WO2002028860A2 Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same
04/11/2002WO2002028858A2 Hexahydropyrazino `1'2' : 1, 6!- pyrido `3, 4-b! indole-1, 4-dione derivatives for the treatment of cardiovascular disorders and erectile disfunction
04/11/2002WO2002028837A1 Metabotropic glutamate receptor antagonists
04/11/2002WO2002028830A1 Novel phenylalanine derivatives
04/11/2002WO2002028820A1 Nitroso diphenylamine derivatives
04/11/2002WO2002028395A1 Phosphoric acid salt of an integrin receptor antagonist
04/11/2002WO2002028390A1 Composition comprising a catalyst for the dismutation of superoxide and use of the composition for preventing and treating hypotension
04/11/2002US20020042419 Administering growth hormone secretagogue
04/11/2002US20020042415 Dipeptide derivatives
04/11/2002US20020042414 Antiallergens
04/11/2002US20020042412 Fused azepinone cyclin dependent kinase inhibitors
04/11/2002US20020042408 Antibiotic compounds
04/11/2002US20020042407 Substituted porphyrins
04/11/2002US20020041978 Organic electroluminescent device
04/11/2002US20020041846 Metal complexes for use in medical and therapeutic applications
04/11/2002CA2425266A1 Composition comprising a catalyst for the dismutation of superoxide and use of the composition for preventing and treating hypotension
04/11/2002CA2425264A1 Tumor proliferation inhibitors
04/11/2002CA2424684A1 Nitroso diphenylamine derivatives
04/11/2002CA2424303A1 Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same
04/11/2002CA2424117A1 Phosphoric acid salt of an integrin receptor antagonist
04/11/2002CA2421782A1 Quinoline and quinolinone derivatives as metabotropic glutamate receptor antagonists
04/10/2002EP1195372A1 N-heterocyclic substituted benzamide derivatives with antihypertensive activity